Abnormal angiogenesis in diabetic nephropathy. - Wikidata - awgldk - TriplyDB

Abnormal angiogenesis in diabetic nephropathy.

Abnormal angiogenesis in diabetic nephropathy.

http://www.wikidata.org/entity/Q37236268

about

Anthocyanin-rich purple corn extract inhibit diabetes-associated glomerular angiogenesis Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?Angiopoietins and diabetic nephropathy Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes Midkine and the kidney: health and diseases Renal endothelial dysfunction in diabetic nephropathy Expression of the growth factor progranulin in endothelial cells influences growth and development of blood vessels: a novel mouse model Vascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db mice Cancer biology in diabetes.Preliminary study of hypoxia-related cardiovascular mediator-markers in patients with end-stage renal disease with and without diabetes and the effects of haemodialysis The Role of SIRT1 in Diabetic Kidney Disease.Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats.Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney Resveratrol attenuates diabetic nephropathy via modulating angiogenesis.Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes.Urinary angiopoietin-2 is associated with albuminuria in patients with type 2 diabetes mellitus.Semaphorin3a promotes advanced diabetic nephropathy BAMBI elimination enhances alternative TGF-β signaling and glomerular dysfunction in diabetic mice Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea Microvascular disease precedes the decline in renal function in the streptozotocin-induced diabetic rat.Novel role of the IGF-1 receptor in endothelial function and repair: studies in endothelium-targeted IGF-1 receptor transgenic mice.Progesterone ameliorates diabetic nephropathy in streptozotocin-induced diabetic Rats Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system.eNOS deficiency predisposes podocytes to injury in diabetes.Imbalance of angiogenesis in diabetic complications: the mechanisms.Aberrant production of extracellular matrix proteins and dysfunction in kidney endothelial cells with a short duration of diabetes Distribution of hydrogen sulfide (H₂S)-producing enzymes and the roles of the H₂S donor sodium hydrosulfide in diabetic nephropathy.Urgent call for reconsideration of chronic kidney disease.C-peptide preserves the renal microvascular architecture in the streptozotocin-induced diabetic rat.Abnormalities in signaling pathways in diabetic nephropathy.Endothelial dysfunction as a potential contributor in diabetic nephropathy.Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.Cellular and molecular mechanisms of diabetic glomerulopathy.VEGF and podocytes in diabetic nephropathy.The renal endothelium in diabetic nephropathy.Cerebral neovascularization in diabetes: implications for stroke recovery and beyond.Reversibility of endothelial dysfunction in diabetes: role of polyphenols.Proposed mechanisms of Terminalia catappa in hyperglycaemia and associated diabetic complications.

P2860

Q21132429-0FF5A7C9-9EB5-4723-AA45-CB702BCB304D Q24629743-269FFADE-021E-4FC1-8D6A-C6F43E8C019F Q26745523-D672B480-74E9-46BE-8394-7BC1D0575629 Q26747192-C4EEEF53-1F46-4120-A5FB-F7A3D966129D Q26778527-A7A7C868-52D5-4977-985F-4FD16910098C Q27005733-9204AE53-EA93-4AE1-96F1-C754362159B9 Q27021318-36732B7A-55A5-4ED1-AFBA-3B8831D8940D Q27317909-8A5B7D32-ED83-48DD-BE9A-27413A5F57A7 Q31159383-8F731DDE-E565-43A3-83DF-638BD7790DE9 Q33608038-47DCB3C5-F40A-4E72-8092-D38737A36804 Q33719168-56742216-75AD-40CB-930C-3A0132B9E477 Q34312543-497554DF-4314-48C4-9EB1-F310FBE62EC5 Q34412951-3849E7D3-D76E-42EF-AC04-EF2956B9A7BC Q34441673-BF65AFE6-761C-4C35-A4FA-A50405C3C9FC Q35026645-D4BBE0CB-4C66-478A-BB74-9A366E823676 Q35061522-2A4632B1-B915-4917-86C1-094ADD85FFC7 Q35073189-3CF46E9D-D392-469A-9929-2A25AFA30665 Q35250569-0312203B-C0B1-4C72-AC70-9F547BD380A4 Q35532272-5C963C0A-48F8-408D-A206-4BC3138DCC81 Q35630822-15D37DD1-80B4-4A9E-8358-9C4A98FA1018 Q35669858-10521C9E-0C34-427B-9687-DEA9806B8F7C Q35780734-0299D86F-FE8F-4B8A-BD1E-B24FAD3A4020 Q36182530-4981A0C7-25BE-458A-9880-958364990DDA Q36292425-8357A2AD-34A8-45B6-9F50-4BCBFD497F2D Q36328641-AB85BBD0-EBD7-4E3B-BC37-3FE23383C99A Q36352132-22010538-A295-437F-8198-32436D646C13 Q36489031-FD26C525-F833-46C6-8EC9-D94CFC1C154B Q36527871-CC60313A-3E34-4ED6-944E-7C3504C7DD4A Q36609773-594981A2-E74D-48BF-A248-C36C7B46846F Q37195423-64BC690A-568C-4E47-99CC-C1398F78AFDB Q37282197-91C48D2F-A529-49AA-8B4A-32D72BD1D24A Q37708046-2640EF38-2163-4C2B-A12F-D3598D8D37D6 Q37806614-113CBBC0-C037-437F-83B4-AA792D8E42E5 Q37934555-B46EA09E-26A7-4D16-9B05-9024DB5714E8 Q38010045-93FF86E6-F99D-4939-BB22-CBD63428D347 Q38041671-44E3688B-7541-4676-AE72-66E48CCE4DE9 Q38087656-C1CABBB9-6B03-40C5-8390-4988F20023E9 Q38185249-A396F811-8FF8-48ED-9B64-78C4E47F11C4 Q38855635-1FFC8C51-AA7A-4B38-BAC7-E97A8B64041A Q39045202-8FB9F24B-6E56-45D2-B80E-160E5A32C765

P2860

Abnormal angiogenesis in diabetic nephropathy.

http://www.wikidata.org/entity/Q37236268

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Abnormal angiogenesis in diabetic nephropathy.

@en

Abnormal angiogenesis in diabetic nephropathy.

@nl

type

label

Abnormal angiogenesis in diabetic nephropathy.

@en

Abnormal angiogenesis in diabetic nephropathy.

@nl

prefLabel

Abnormal angiogenesis in diabetic nephropathy.

@en

Abnormal angiogenesis in diabetic nephropathy.

@nl

P1433

Q37236268-DA20A35E-9B7D-4B33-99D3-767C07FB0839

P1476

Q37236268-4ED7F68D-3F94-478B-A8F0-71DEE2337C97

P2093

Q37236268-289BC824-4D3E-45DA-9017-763AA0125C60

Q37236268-6B4FF2D6-06A6-4FFE-8B1F-BB67B7DFD7F9

Q37236268-7B0F988F-CC07-4EDE-8B04-11C6C047DAD0

Q37236268-87FE1B76-EF4C-4F5C-A604-035357F082EA

P2860

Q37236268-13B4EA7F-652D-4656-AEF4-3E6E5141C455

Q37236268-143C3FB5-B2A2-451E-9847-6ADAB0748232

Q37236268-14A8AE35-FEB2-4EDA-93F6-88732A6B6551

Q37236268-18F3DDA5-8DFA-4C07-841A-095BCFA15AF9

Q37236268-214299EB-14DA-4155-8E2F-A9E81B5AD3EC

Q37236268-2CDAB196-4D82-4E0B-8267-4924C8B9569D

Q37236268-345B4A06-649F-4088-9E0F-907768BEABA8

Q37236268-360DCA1A-0289-4152-8DF5-6D645C881BDC

Q37236268-37568FBC-AD0C-4B7A-90B3-38C243C3F4CF

Q37236268-390B5727-ED88-4F20-9542-BD5C922AF1B3

P304

Q37236268-7C271CD1-CE13-4C0A-9C2A-135DE4FDE279

P31

Q37236268-CD5B22E7-E161-4E57-BBF1-70A1B0EBB51D

P356

Q37236268-6B47BCC7-E509-4FBC-B866-9C05AAF2ED0F

P407

Q37236268-CF99F9B7-7660-4FC2-A528-B2E4ACE31B73

P433

Q37236268-8B060EB1-3D5A-490D-9A8E-762687436649

P478

Q37236268-B78335ED-47B7-4F2E-9704-A93E90C894B9

P50

Q37236268-2E45039F-51DF-4931-853C-01E86B411799

P577

Q37236268-58EFF3F9-B4A8-4931-B540-199F07AB5853

P5875

Q37236268-496D32BD-6421-461A-A0A0-6C9C66AD56AE

P698

Q37236268-4CF3E470-FC7D-428B-B134-22B12796AF5C

P932

Q37236268-1809EE8D-A6BB-4297-8308-3CDF8CE0C068

P356

P1433

P1476

Abnormal angiogenesis in diabetic nephropathy

@en

P2093

Christopher J Rivard

http://www.w3.org/2001/XMLSchema#string

Masakazu Haneda

http://www.w3.org/2001/XMLSchema#string

Takahiko Nakagawa

http://www.w3.org/2001/XMLSchema#string

Tomoki Kosugi

http://www.w3.org/2001/XMLSchema#string

P2860

Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

VEGF inhibition and renal thrombotic microangiopathy

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

VEGF(165) mediates glomerular endothelial repair

Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Structural changes in renal arterioles in Type I diabetic patients.

Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss.

Management of diabetic retinopathy: a systematic review.

P304

1471-1478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB09-0119

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26328480

http://www.w3.org/2001/XMLSchema#string

P698

19564458

http://www.w3.org/2001/XMLSchema#string

P932

2699857

http://www.w3.org/2001/XMLSchema#string